Design and synthesis of endoperoxide antimalarial prodrug models
被引:51
作者:
O'Neill, PM
论文数: 0引用数: 0
h-index: 0
机构:
Univ Liverpool, Robert Robinson Labs, Dept Chem, Liverpool L69 7ZD, Merseyside, EnglandUniv Liverpool, Robert Robinson Labs, Dept Chem, Liverpool L69 7ZD, Merseyside, England
O'Neill, PM
[1
]
Stocks, PA
论文数: 0引用数: 0
h-index: 0
机构:Univ Liverpool, Robert Robinson Labs, Dept Chem, Liverpool L69 7ZD, Merseyside, England
Stocks, PA
Pugh, MD
论文数: 0引用数: 0
h-index: 0
机构:Univ Liverpool, Robert Robinson Labs, Dept Chem, Liverpool L69 7ZD, Merseyside, England
Pugh, MD
Araujo, NC
论文数: 0引用数: 0
h-index: 0
机构:Univ Liverpool, Robert Robinson Labs, Dept Chem, Liverpool L69 7ZD, Merseyside, England
Araujo, NC
Korshin, EE
论文数: 0引用数: 0
h-index: 0
机构:Univ Liverpool, Robert Robinson Labs, Dept Chem, Liverpool L69 7ZD, Merseyside, England
Korshin, EE
Bickley, JF
论文数: 0引用数: 0
h-index: 0
机构:Univ Liverpool, Robert Robinson Labs, Dept Chem, Liverpool L69 7ZD, Merseyside, England
Bickley, JF
Ward, SA
论文数: 0引用数: 0
h-index: 0
机构:Univ Liverpool, Robert Robinson Labs, Dept Chem, Liverpool L69 7ZD, Merseyside, England
Ward, SA
Bray, PG
论文数: 0引用数: 0
h-index: 0
机构:Univ Liverpool, Robert Robinson Labs, Dept Chem, Liverpool L69 7ZD, Merseyside, England
Bray, PG
Pasini, E
论文数: 0引用数: 0
h-index: 0
机构:Univ Liverpool, Robert Robinson Labs, Dept Chem, Liverpool L69 7ZD, Merseyside, England
Pasini, E
Davies, J
论文数: 0引用数: 0
h-index: 0
机构:Univ Liverpool, Robert Robinson Labs, Dept Chem, Liverpool L69 7ZD, Merseyside, England
Davies, J
Verissimo, E
论文数: 0引用数: 0
h-index: 0
机构:Univ Liverpool, Robert Robinson Labs, Dept Chem, Liverpool L69 7ZD, Merseyside, England
Verissimo, E
Bachi, MD
论文数: 0引用数: 0
h-index: 0
机构:Univ Liverpool, Robert Robinson Labs, Dept Chem, Liverpool L69 7ZD, Merseyside, England
Bachi, MD
机构:
[1] Univ Liverpool, Robert Robinson Labs, Dept Chem, Liverpool L69 7ZD, Merseyside, England
[2] Weizmann Inst Sci, Dept Organ Chem, IL-76100 Rehovot, Israel
[3] Univ Liverpool Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England
A masked combination chemotherapy which relies on the embedding of a number of active components, in a latent form, within a single endoperoxidic chemical entity is the aim of the research presented. The approach is illustrated by means of purposely designed bicyclic endoperoxide prodrug prototypes 1 and subsequently validated through the study of model compounds 2 (Ar= Ph, p-FC 6H4, p-ClC6H4.